Jenkem Technology Co P/FCF

Que fait Jenkem Technology Co ? Jenkem Technology Co., Ltd. generates revenue through the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. The company's primary products are sold to pharmaceutical companies, research institutions, and medical device manufacturers that use these materials in drug development and production. Technical services such as patent and non-patent technology licensing, as well as R&D services, also contribute to the company's income. The firm's customer segments include entities involved in drug research, development, and production, as well as scientific research organizations. The company's business model focuses on providing specialized materials and technical support for the medical and pharmaceutical sectors. Medical polyethylene glycol and its active derivatives serve as critical components in various medical applications, driving demand from industry partners. By offering both physical products and intellectual property services, Jenkem Technology diversifies its revenue streams within the healthcare technology space. Jenkem Technology Co., Ltd. operates with a clear focus on the medical and pharmaceutical industries, targeting clients that require high-quality PEG-based materials for their research and manufacturing processes. The company's technical services, including licensing and R&D support, further strengthen its position as a supplier of essential materials and solutions in the healthcare sector. Jenkem Technology Co est l'une des entreprises les plus populaires sur Eulerpool.